Related Experiment Video
Updated: Aug 13, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1
1Department of Medicine, Herbert Irving Comprehensive Cancer Center, College of Physicians & Surgeons, Columbia University, New York, New York 10032, USA.
Abstract:
We recently obtained evidence that treatment of human colon cancer cells with exisulind (sulindac sulfone) and related compounds induces apoptosis by activation of protein kinase G (PKG) and c-Jun kinase (JNK1). The present study further explores this mechanism. We demonstrate that in NIH3T3 cells a constitutively active mutant of PKG causes a dose-dependent activation of JNK1 and thereby transactivates c-Jun and stimulates transcription from the AP-1 enhancer element. The activation of JNK1 and the transactivation of c-Jun by this mutant of PKG were inhibited by a dominant negative MEKK1. In vitro assays showed that a purified PKG directly phosphorylated the N-terminal domain of MEKK1. PKG also directly phosphorylated a full-length MEKK1, and this was associated with enhanced MEKK1 phosphorylation. Thus, it appears that PKG activates JNK1 through a novel PKG-MEKK1-SEK1-JNK1 pathway, by directly phosphorylating and activating MEKK1.
Insights
Exisulind induces colon cancer cell death by activating protein kinase G (PKG) and c-Jun kinase (JNK1). PKG directly phosphorylates MEKK1, initiating a novel pathway that activates JNK1 and promotes apoptosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Exisulind and related compounds induce apoptosis in colon cancer cells.
- This apoptosis is mediated by the activation of protein kinase G (PKG) and c-Jun kinase (JNK1).
Purpose of the Study:
- To further elucidate the mechanism by which PKG and JNK1 activation leads to apoptosis.
- To investigate the role of MEKK1 in the PKG-mediated activation of JNK1.
Main Methods:
- Utilized NIH3T3 cells expressing a constitutively active mutant of PKG.
- Employed dominant-negative MEKK1 to inhibit JNK1 activation.
- Performed in vitro phosphorylation assays using purified PKG and MEKK1.
Main Results:
- Constitutively active PKG dose-dependently activated JNK1 and transactivated c-Jun.
- PKG-induced JNK1 activation and c-Jun transactivation were blocked by dominant-negative MEKK1.
- Purified PKG directly phosphorylated MEKK1, enhancing its activity.
Conclusions:
- PKG activates JNK1 through a novel pathway involving direct phosphorylation and activation of MEKK1.
- This PKG-MEKK1-SEK1-JNK1 pathway is crucial for exisulind-induced apoptosis in colon cancer cells.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways